Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML

Clinical trial NCT00069992 · TERMINATED

Trial details

NCT number: NCT00069992
Sponsor: Baylor College of Medicine
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloproliferative Disorders Leukemia Myelodysplastic Syndromes

Start date: 2001-12-01
Primary completion: 2006-09-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.